Trastuzumab Recruiting Phase 3 Trials for Metastatic Breast Cancer (MBC) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Recruiting | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT03262935 | SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer | |
NCT02344472 | Detect V / CHEVENDO (Chemo vs. Endo) |